Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome
This is why the no-DAC form is pharmacologically a different proposition from the DAC form, despite sharing a name
J Clin Oncol 28:44854491 Wilson P, Anastasaki A, Owen MR, Kempe K, Haddleton DM, Mann SK, Johnston AP, Quinn JF, Whittaker MR et al (2015) Organic arsenicals as efficient and highly specific linkers for protein/peptidepolymer conjugation
Quist DA, Diaz DE, Liu JJ, Karlin KD (2017) Activation of dioxygen by copper metalloproteins and insights from model complexes